AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2010
Feb 8, 2010
30016_dirs_2010-02-08_dd3f743b-d525-4626-a7b0-b123bc7f3ee6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2010-02-04
Reporting Person: WALLEN WILLIAM C (Senior VP & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-04 | Common Stock | M | 10000 | $21.3000 | Acquired | 28668 | Direct |
| 2010-02-04 | Common Stock | S | 10000 | $50.3224 | Disposed | 18668 | Direct |
| 2010-02-08 | Common Stock | M | 13530 | $21.3000 | Acquired | 32198 | Direct |
| 2010-02-08 | Common Stock | S | 13530 | $50.00 | Disposed | 18668 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-04 | Non-Qualified Stock Options (right to buy) | $21.3000 | M | 10000 | Disposed | 2013-09-08 | Common Stock (10000) | Direct |
| 2010-02-08 | Non-Qualified Stock Options (right to buy) | $21.30 | M | 13530 | Disposed | 2013-09-08 | Common Stock (13530) | Direct |
Footnotes
F1: The sale price reported above reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged between $50.20 and $50.41. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Includes 54 shares of common stock acquired pursuant to the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2009.
F3: Grant of options to buy shares of common stock becomes exercisable in five equal annual increments, beginning on the first anniversary date (9/8/2004) of the date of grant.